Latest 10-K annual reports

Baltic International USA, Inc. files its annual report on Form 10-K, highlighting its ongoing efforts to identify and acquire a target company while navigating minimal assets and a history of operating losses.

Hyperscale Data, Inc. files its 10-K report for fiscal year 2024, detailing financial results and a strategic pivot from Bitcoin mining to AI and high-performance computing.

BranchOut Food Inc.'s 2024 annual report reveals a year of strategic expansion, including the launch of a new production facility in Peru, alongside ongoing financial challenges and a net loss of $4.75 million.

SS Innovations International's 2024 10-K filing reveals a significant revenue increase driven by surgical robotic system sales, but also highlights substantial doubt about the company's ability to continue as a going concern due to recurring losses and dependence on external funding.

MediaCo Holding Inc.'s 2024 10-K filing highlights the impact of the Estrella Acquisition on revenue growth and strategic focus on multicultural audiences.

Constellium SE files an amendment to its 2024 Annual Report on Form 10-K, updating information on executive compensation, security ownership, and the equity incentive plan.

GeoSolar Technologies, still in its development stage, reports a net loss of $1.54 million for 2024 while initiating revenue generation through its SmartGreen Home system.

New Momentum Corporation's 10-K filing reveals a net loss for 2024 and expresses substantial doubt about the company's ability to continue as a going concern.

Adverum Biotechnologies' 10-K filing reveals substantial doubt about its ability to continue as a going concern due to recurring losses, a material weakness in internal controls, and the need for additional funding.

Spruce Biosciences reports significant net losses and raises substantial doubt about its ability to continue as a going concern despite advancements in its clinical development programs.

GivBux Inc.'s 2024 10-K filing highlights a significant increase in revenue driven by transactional and subscription growth, alongside a substantial net loss due to increased operating expenses and stock-based compensation.

Koil Energy Solutions, Inc. reports a 48% increase in revenue for 2024, driven by fixed price contracts, but identifies material weaknesses in internal control over financial reporting.

Blaize Holdings, Inc. files its 2024 10-K, detailing its business strategy, financial performance, and risk factors following its merger with BurTech Acquisition Corporation.

IMAC Holdings transitions to proteomic services, acquiring Theralink assets, while grappling with Nasdaq delisting due to Minimum Equity Rule non-compliance.

Applied Therapeutics receives a Complete Response Letter from the FDA for its Galactosemia drug, prompting a strategic shift towards Sorbitol Dehydrogenase (SORD) Deficiency treatment.

Yunhong Green CTI Ltd.'s 2024 Form 10-K reveals strategic shifts, financial challenges, and efforts to maintain NASDAQ listing compliance.

Pioneer Power Solutions reports a significant increase in revenue for its Critical Power segment, driven by mobile EV charging solutions, despite identifying a material weakness in internal controls.

Papaya Growth Opportunity Corp. I's 10-K filing reveals a company struggling to find a business combination target as its deadline approaches, shares delist, and redemptions deplete its trust account.

Nexalin Technology files an amendment to its 2024 annual report to include the Insider Trading Policy and Compensation Recoupment Policy exhibits.

CareView Communications files an amendment to its annual report on Form 10-K to revise information regarding the security ownership of certain beneficial owners and management.

Cyber Enviro-Tech, Inc. reports a net loss of $6.37 million for 2024, driven by increased asset impairment and operating expenses, as the company focuses on water and oil remediation and plans to spin off its Alvey oil field.

iSpecimen Inc.'s annual report reveals a net loss of $12.5 million for 2024 and raises substantial doubt about the company's ability to continue as a going concern.

Healthier Choices Management Corp. (HCMC) reports its fiscal year 2024 results, highlighting the spin-off of its grocery segment, ongoing patent litigation, and efforts to manage its intellectual property portfolio.

Nukkleus Inc. files an amendment to its annual report to include information on its policy for recovering erroneously awarded compensation, while also detailing its business strategy, recent developments, and financial performance.

Contango Ore, Inc. files an amendment to its annual report to include its policy regarding the mandatory recovery of compensation from executive officers in the event of a financial restatement.

Two Hands Corporation reports a net loss for fiscal year 2024 and announces a strategic shift away from wholesale food distribution to focus on artisan denim and premium cotton yarns.

Skinvisible, Inc. files its 10-K for the year ended December 31, 2024, highlighting ongoing efforts to license its Invisicare technology and advancements in clinical trials by its licensee, Quoin Pharmaceuticals.

Emmaus Life Sciences' 10-K filing reveals a significant revenue drop in 2024 and raises substantial doubt about the company's ability to continue as a going concern.

REMSleep Holdings, Inc. reports a net loss for 2024 but recognizes revenue from ResPlus CPAP system sales and continues development of its DeltaWave product.

Stran & Company's 2024 10-K filing reveals an 8.8% increase in sales offset by a net loss due to rising operating expenses, acquisition costs, and identified material weaknesses in internal controls.